|
Real-time
CBOE
21:29:48 24/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.200 USD | -4.65% |
|
-0.35% | -18.02% |
| 08-25 | Immatics Announces $150 Million Underwritten Offering | MT |
| 08-18 | Immatics' Q2 Net Loss Narrows as Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 74.18B | |||||
| 59.55B | |||||
| 25.84B | - | ||||
| 24.73B | - | ||||
| 20.87B |
Select your edition
All financial news and data tailored to specific country editions
